OBJECTIVE: Unhelpful behavior related to irritable bowel syndrome (IBS) is often targeted and expected to change in treatments such as cognitive behavioral therapies. However, no scale has previously been produced to assess these dimensions. The aim of this study was to develop and validate an IBS-specific behavioral responses questionnaire. METHODS: A total of 153 patients with IBS as diagnosed by a general practitioner completed the 28-item Irritable Bowel Syndrome-Behavioral Responses Questionnaire (IBS-BRQ). A total of 117 persons without IBS also completed the IBS-BRQ and were used as a control group. Tests of internal consistency and principal components analyses (PCAs) were performed on both sets of data. RESULTS: The scale was found to be both reliable and valid with a high degree of internal consistency for both IBS patients (Cronbach's alpha=.86) and controls (Cronbach's alpha=.89). The scale differentiated significantly between IBS patients and controls (F=221, P<.01). The PCA supported a two-factor solution in both sets of data. Two items were removed from the scale due to low discriminative ability. The criterion validity was high as evidenced by a strong correlation with the Cognitive Scale for Functional Bowel Disorders (CS-FBD) (r =.67, P<.001). CONCLUSION: The IBS-BRQ is a valid and reliable scale that can be used for clinical as well as empirical purposes. Copyright (c) 2010 Elsevier Inc. All rights reserved.
OBJECTIVE: Unhelpful behavior related to irritable bowel syndrome (IBS) is often targeted and expected to change in treatments such as cognitive behavioral therapies. However, no scale has previously been produced to assess these dimensions. The aim of this study was to develop and validate an IBS-specific behavioral responses questionnaire. METHODS: A total of 153 patients with IBS as diagnosed by a general practitioner completed the 28-item Irritable Bowel Syndrome-Behavioral Responses Questionnaire (IBS-BRQ). A total of 117 persons without IBS also completed the IBS-BRQ and were used as a control group. Tests of internal consistency and principal components analyses (PCAs) were performed on both sets of data. RESULTS: The scale was found to be both reliable and valid with a high degree of internal consistency for both IBSpatients (Cronbach's alpha=.86) and controls (Cronbach's alpha=.89). The scale differentiated significantly between IBSpatients and controls (F=221, P<.01). The PCA supported a two-factor solution in both sets of data. Two items were removed from the scale due to low discriminative ability. The criterion validity was high as evidenced by a strong correlation with the Cognitive Scale for Functional Bowel Disorders (CS-FBD) (r =.67, P<.001). CONCLUSION: The IBS-BRQ is a valid and reliable scale that can be used for clinical as well as empirical purposes. Copyright (c) 2010 Elsevier Inc. All rights reserved.
Authors: Tom G Mayer; Randy Neblett; Howard Cohen; Krista J Howard; Yun H Choi; Mark J Williams; Yoheli Perez; Robert J Gatchel Journal: Pain Pract Date: 2011-09-27 Impact factor: 3.183
Authors: Marianne Bonnert; Ola Olén; Maria Lalouni; Marc A Benninga; Matteo Bottai; Johanna Engelbrektsson; Erik Hedman; Fabian Lenhard; Bo Melin; Magnus Simrén; Sarah Vigerland; Eva Serlachius; Brjánn Ljótsson Journal: Am J Gastroenterol Date: 2016-11-15 Impact factor: 10.864
Authors: Brjánn Ljótsson; Gerhard Andersson; Erik Andersson; Erik Hedman; Perjohan Lindfors; Sergej Andréewitch; Christian Rück; Nils Lindefors Journal: BMC Gastroenterol Date: 2011-10-12 Impact factor: 3.067
Authors: Hazel Everitt; Sabine Landau; Paul Little; Felicity L Bishop; Paul McCrone; Gilly O'Reilly; Nicholas Coleman; Robert Logan; Trudie Chalder; Rona Moss-Morris Journal: BMJ Open Date: 2015-07-15 Impact factor: 2.692
Authors: Maria Lalouni; Ola Olén; Marianne Bonnert; Erik Hedman; Eva Serlachius; Brjánn Ljótsson Journal: PLoS One Date: 2016-10-13 Impact factor: 3.240
Authors: Hugo Wallén; Perjohan Lindfors; Erik Andersson; Erik Hedman-Lagerlöf; Hugo Hesser; Nils Lindefors; Cecilia Svanborg; Brjánn Ljótsson Journal: BMC Gastroenterol Date: 2021-07-13 Impact factor: 3.067
Authors: Brjánn Ljótsson; Erik Andersson; Perjohan Lindfors; Jeffrey M Lackner; Karin Grönberg; Katarina Molin; Johanna Norén; Karin Romberg; Evelyn Andersson; Timo Hursti; Hugo Hesser; Erik Hedman Journal: BMC Gastroenterol Date: 2013-11-19 Impact factor: 3.067